Indian Company Master Data Made Simple
Sms Pharmaceuticals Limited
Founded in 1987, Sms Pharmaceuticals Limited has been operating for more than 38 years. It is registered under CIN L24239TG1987PLC008066 and registration number 8066. Sms Pharmaceuticals Limited is registered as company limited by shares. Sms Pharmaceuticals Limited is authorized to hold share capital worth ₹12.00 crore. Its paid up capital is ₹8.47 crore.
The company specializes in manufacture of chemicals and chemical products operations. The company’s registration location is Hyderabad. The company’s incorporation address is Plot No. 72, H.no: 8-2-334/3&4, Road No. 5 Opp. Sbi Executive Enclave, Banjara Hill, S, Hyderabad, Hyderabad, Telangana, India, 500034. The company maintains an active registration. The entity’s LEI (Legal Entity Identifier) number is 335800XXEADQCB7GJ514. You can reach the company via email at [email protected]. The company is led by Lakshmi Narayana Tammineedi (CFO).
Profile data last updated: 16/12/2024
Company Overview
- CIN
- Date of Incorporation
- 14/12/1987
- Company Status
- Active
- RoC
- Hyderabad
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹12,00,00,000.00
- Paid up Capital
- ₹8,46,52,030.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2017 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹18,866.83L | ₹16,604.53L | ₹16,417.14L | ₹19,273.28L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹51,303.69L | ₹49,776.37L | ₹41,908.49L | ₹38,921.31L | ₹0.00L |
| Accumulated Depreciation | -₹22,222.85L | -₹18,971.09L | -₹16,016.70L | -₹12,960.93L | ₹0.00L |
| Tangible Book Value | ₹63,751.47L | ₹53,366.94L | ₹45,905.96L | ₹46,891.85L | ₹0.00L |
| Long Term Debt | ₹13,936.42L | ₹12,208.63L | ₹12,113.33L | ₹14,950.15L | ₹0.00L |
| Long Term Provisions | ₹120.65L | ₹116.01L | ₹140.45L | ₹175.92L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹17,139.15L | ₹15,868.42L | ₹13,232.00L | ₹11,165.26L | ₹0.00L |
| Total Assets | ₹1,15,268.13L | ₹1,03,409.26L | ₹87,961.01L | ₹85,950.17L | ₹0.00L |
| Machinery Furniture Equipment | ₹56,242.28L | ₹45,769.93L | ₹42,379.87L | ₹41,878.22L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹63,964.44L | ₹53,632.89L | ₹46,052.52L | ₹47,028.86L | ₹0.00L |
| Gross PPE | ₹79,674.01L | ₹66,845.26L | ₹60,951.98L | ₹58,153.51L | ₹0.00L |
| Common Stock | ₹886.52L | ₹846.52L | ₹846.52L | ₹846.52L | ₹0.00L |
| Total Capitalization | ₹77,900.85L | ₹65,841.52L | ₹58,165.85L | ₹61,979.01L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹212.96L | ₹265.95L | ₹146.56L | ₹137.01L | ₹0.00L |
| Total Debt | ₹31,075.57L | ₹28,077.05L | ₹25,406.69L | ₹26,326.85L | ₹0.00L |
| Other Equity Interest | ₹1,587.50L | ₹2,857.50L | ₹45,206.00L | ₹46,182.34L | ₹0.00L |
| Capital Stock | ₹886.52L | ₹846.52L | ₹846.52L | ₹846.52L | ₹0.00L |
| Additional Paid In Capital | ₹12,176.84L | ₹7,136.84L | ₹7,136.84L | ₹7,136.84L | ₹0.00L |
| Total Non Current Assets | ₹59,821.33L | ₹50,019.78L | ₹46,896.15L | ₹48,245.06L | ₹0.00L |
| Invested Capital | ₹95,040.00L | ₹81,650.76L | ₹71,303.86L | ₹73,040.23L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹4,149.05L | ₹3,611.60L | ₹737.78L | ₹4,658.28L | ₹0.00L |
| Net Tangible Assets | ₹63,751.47L | ₹53,366.94L | ₹45,905.96L | ₹46,891.85L | ₹0.00L |
| Prepaid Assets | ₹870.59L | ₹1,483.51L | ₹1,347.17L | ₹1,136.75L | ₹0.00L |
| Cash And Cash Equivalents | ₹4,139.91L | ₹3,603.95L | ₹730.78L | ₹4,658.28L | ₹0.00L |
| Stockholders Equity | ₹63,964.43L | ₹53,632.89L | ₹46,052.52L | ₹47,028.86L | ₹0.00L |
| Other Short Term Investments | ₹9.14L | ₹7.65L | ₹7.00L | ₹35.30L | ₹0.00L |
| Share Issued | ₹886.52L | ₹846.52L | ₹846.52L | ₹846.52L | ₹0.00L |
| Current Assets | ₹55,446.80L | ₹53,389.48L | ₹41,064.86L | ₹37,705.11L | ₹0.00L |
| Working Capital | ₹23,009.94L | ₹20,217.64L | ₹15,573.51L | ₹18,057.08L | ₹0.00L |
| Net Debt | ₹26,935.66L | ₹24,413.92L | ₹24,520.56L | ₹21,353.09L | ₹0.00L |
| Ordinary Shares Number | ₹886.52L | ₹846.52L | ₹846.52L | ₹846.52L | ₹0.00L |
| Current Debt | ₹17,139.15L | ₹15,809.24L | ₹13,138.01L | ₹11,061.22L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹13,936.42L | ₹12,208.63L | ₹12,174.69L | ₹15,161.59L | ₹0.00L |
| Current Liabilities | ₹32,436.86L | ₹33,171.84L | ₹25,491.35L | ₹19,648.03L | ₹0.00L |
| Retained Earnings | ₹38,009.29L | ₹32,487.75L | ₹28,764.88L | ₹29,741.22L | ₹0.00L |
| Net PPE | ₹57,451.16L | ₹47,874.17L | ₹44,935.28L | ₹45,192.58L | ₹0.00L |
| Construction In Progress | ₹4,366.37L | ₹4,414.29L | ₹3,880.09L | ₹1,530.45L | ₹0.00L |
| Common Stock Equity | ₹63,964.43L | ₹53,632.89L | ₹46,052.52L | ₹47,028.86L | ₹0.00L |
| Other Non Current Assets | ₹899.23L | ₹1,387.12L | ₹561.04L | ₹430.06L | ₹0.00L |
| Other Intangible Assets | ₹212.96L | ₹265.95L | ₹146.56L | ₹137.01L | ₹0.00L |
| Inventory | ₹28,472.92L | ₹23,369.78L | ₹22,349.94L | ₹25,109.75L | ₹0.00L |
| Other Properties | ₹2,983.85L | ₹2,828.88L | ₹1,192.61L | ₹1,318.83L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2017 |
|---|---|---|---|---|---|
| Changes In Cash | ₹535.97L | ₹2,873.17L | -₹3,927.50L | ₹615.97L | ₹0.00L |
| Financing Cash Flow | ₹4,707.92L | ₹3,067.90L | -₹3,196.89L | -₹1,174.70L | ₹0.00L |
| Free Cash Flow | -₹4,167.06L | -₹203.53L | -₹747.07L | ₹1,781.23L | ₹0.00L |
| Investing Cash Flow | -₹12,342.87L | -₹5,207.20L | -₹2,975.61L | -₹2,715.30L | ₹0.00L |
| End Cash Position | ₹4,139.91L | ₹3,603.95L | ₹737.78L | ₹4,658.28L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | -₹0.01L | ₹0.00L | ₹7.00L | -₹0.01L | ₹0.00L |
| Capital Expenditure | -₹12,337.98L | -₹5,216.00L | -₹2,992.07L | -₹2,724.74L | ₹0.00L |
| Beginning Cash Position | ₹3,603.95L | ₹730.78L | ₹4,658.28L | ₹4,042.31L | ₹0.00L |
| Issuance Of Capital Stock | ₹3,809.03L | ₹2,847.78L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Cash Flow | ₹8,170.92L | ₹5,012.47L | ₹2,245.00L | ₹4,505.97L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2017 |
|---|---|---|---|---|---|
| Rent Expense Supplemental | ₹41.72L | ₹7.17L | ₹8.04L | ₹9.39L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹6,913.56L | ₹4,982.60L | -₹705.93L | ₹6,221.99L | ₹0.00L |
| EBITDA | ₹14,410.96L | ₹12,024.02L | ₹5,846.89L | ₹11,880.82L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items | ₹2.05L | ₹3.72L | -₹5.44L | -₹0.37L | ₹0.00L |
| Total Expenses | ₹67,460.72L | ₹62,120.83L | ₹49,726.54L | ₹43,254.68L | ₹0.00L |
| Operating Revenue | ₹77,927.40L | ₹70,645.65L | ₹51,974.68L | ₹51,501.58L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.55L | ₹0.95L | -₹1.49L | -₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹2.05L | ₹3.72L | -₹5.44L | -₹0.37L | ₹0.00L |
| Interest Income Non Operating | ₹68.69L | ₹75.79L | ₹77.48L | ₹55.96L | ₹0.00L |
| Interest Expense Non Operating | ₹1,743.48L | ₹2,261.77L | ₹2,099.44L | ₹1,815.66L | ₹0.00L |
| Interest Income | ₹68.69L | ₹75.79L | ₹77.48L | ₹55.96L | ₹0.00L |
| General And Administrative Expense | ₹741.95L | ₹947.42L | ₹549.79L | ₹494.76L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹6,913.56L | ₹4,982.60L | -₹705.93L | ₹6,221.99L | ₹0.00L |
| Reconciled Depreciation | ₹3,433.73L | ₹3,151.57L | ₹3,212.54L | ₹3,215.25L | ₹0.00L |
| Net Income Continuous Operations | ₹6,913.50L | ₹4,982.60L | -₹705.93L | ₹6,221.99L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹52,340.89L | ₹49,770.79L | ₹39,060.77L | ₹33,358.60L | ₹0.00L |
| Net Income | ₹6,913.56L | ₹4,982.60L | -₹705.93L | ₹6,221.99L | ₹0.00L |
| Operating Income | ₹10,466.68L | ₹8,524.82L | ₹2,248.14L | ₹8,246.90L | ₹0.00L |
| Diluted Average Shares | ₹886.52L | ₹846.52L | ₹846.52L | ₹846.52L | ₹0.00L |
| Selling And Marketing Expense | ₹1,375.31L | ₹473.17L | ₹382.27L | ₹342.09L | ₹0.00L |
| Normalized Income | ₹6,912.06L | ₹4,979.83L | -₹701.98L | ₹6,222.36L | ₹0.00L |
| Total Other Finance Cost | ₹110.61L | ₹97.80L | ₹97.98L | ₹100.73L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹1,785.40L | -₹2,283.78L | -₹2,119.94L | -₹1,860.43L | ₹0.00L |
| EBIT | ₹10,977.23L | ₹8,872.45L | ₹2,634.35L | ₹8,665.57L | ₹0.00L |
| Gross Profit | ₹25,586.51L | ₹20,874.86L | ₹12,913.91L | ₹18,142.98L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹6,913.56L | ₹4,982.60L | -₹705.93L | ₹6,221.99L | ₹0.00L |
| Cost Of Revenue | ₹52,340.89L | ₹49,770.79L | ₹39,060.77L | ₹33,358.60L | ₹0.00L |
| Net Interest Income | -₹1,785.40L | -₹2,283.78L | -₹2,119.94L | -₹1,860.43L | ₹0.00L |
| Normalized EBITDA | ₹14,408.91L | ₹12,020.30L | ₹5,852.33L | ₹11,881.19L | ₹0.00L |
| Operating Expense | ₹15,119.83L | ₹12,350.04L | ₹10,665.77L | ₹9,896.08L | ₹0.00L |
| Net Income Common Stockholders | ₹6,913.56L | ₹4,982.60L | -₹705.93L | ₹6,221.99L | ₹0.00L |
| Pretax Income | ₹9,233.75L | ₹6,610.68L | ₹534.91L | ₹6,849.91L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹77,927.40L | ₹70,645.65L | ₹51,974.68L | ₹51,501.58L | ₹43,925.66L |
| Selling General And Administration | ₹2,117.26L | ₹1,420.59L | ₹932.06L | ₹836.85L | ₹0.00L |
| Other Operating Expenses | ₹583.05L | ₹525.12L | ₹469.31L | ₹454.98L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹1,743.48L | ₹2,261.77L | ₹2,099.44L | ₹1,815.66L | ₹0.00L |
| Basic Average Shares | ₹886.52L | ₹846.52L | ₹846.52L | ₹846.52L | ₹0.00L |
| Tax Provision | ₹2,493.93L | ₹1,690.68L | ₹146.50L | ₹61.82L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹6,913.50L | ₹4,982.60L | -₹705.93L | ₹6,221.99L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 01/12/2008 | Ramesh Babu Potluri | 00166381 | Managing Director | View other directorships |
| 13/09/2017 | Lakshmi Narayana Tammineedi | *****3793B | CFO | |
| 26/05/2018 | Shravan Kudaravalli | 06905851 | Director | View other directorships |
| 12/08/2019 | Srinivas Sarvepalli | 02292051 | Director | View other directorships |
| 05/06/2020 | Vamsi Krishna Potluri | 06956498 | Whole-time director | View other directorships |
| 16/02/2022 | Thirumalesh Tumma | *****4603L | Company Secretary | |
| 12/08/2024 | Suresh Kumar Gangavarapu | 00183128 | Director | View other directorships |
| 12/08/2024 | Shanti Sree Bolleni | 07092258 | Director | View other directorships |
| 12/08/2024 | Trilok Potluri | 07634613 | Director | View other directorships |
| 12/08/2024 | Sunkara Venkata Satya Shiva Prasad | 10404277 | Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 01/12/2024 | Form MGT-7-26112024 | - |
| 07/11/2024 | Form AOC-4(XBRL)-30102024 | - |
| 30/10/2024 | Form AOC-4(XBRL)-30102024 | - |
| 06/04/2024 | Form Addendum to AOC-4 CSR-06042024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Denis Chem Lab Limited | L24230GJ1980PLC003843 | Block No 457chhatral, Kalol, Gujarat, India, 382729 |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Plot No. 72, H.no: 8-2-334/3&4, Road No. 5 Opp. Sbi Executive Enclave, Banjara Hill, S, Hyderabad, Hyderabad, Telangana, India, 500034
FAQ
What is the incorporation date of Sms Pharmaceuticals Limited?
The incorporation date of Sms Pharmaceuticals Limited is 14/12/1987.
Who are the current board members & directors of Sms Pharmaceuticals Limited?
The current board member of Sms Pharmaceuticals Limited are:
- Ramesh Babu Potluri
- Vamsi Krishna Potluri
- Shravan Kudaravalli
- Srinivas Sarvepalli
- Suresh Kumar Gangavarapu
- Shanti Sree Bolleni
- Trilok Potluri
- Sunkara Venkata Satya Shiva Prasad
What is the registered address of Sms Pharmaceuticals Limited?
The registered address of Sms Pharmaceuticals Limited is Plot No. 72, H.no: 8-2-334/3&4, Road No. 5 Opp. Sbi Executive Enclave, Banjara Hill, S, Hyderabad, Hyderabad, Telangana, India, 500034.
What is the Corporate Identification Number of Sms Pharmaceuticals Limited?
The Corporate Identification Number of Sms Pharmaceuticals Limited is L24239TG1987PLC008066.